✦ LIBER ✦

The immune response to Epstein-Barr nuclear antigen: Conformational and structural features of antibody binding to synthetic peptides

✍ Scribed by Gary Rhodes; Richard Houghten; Joseph P. Taulane; Dennis Carson; John Vaughan

Book ID: 119089385
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 801 KB
Volume: 21
Category: Article
ISSN: 0161-5890
DOI: 10.1016/0161-5890(84)90114-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human T cell responses to the Epstein-Ba

Human T cell responses to the Epstein-Barr nuclear antigen-1 (EBNA-1) as evaluated by synthetic peptides

✍ Jørgen Petersen; Gary Rhodes; Kevin Patrick; Jean Roudier; John H. Vaughan 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Antibody reactivity to a synthetic pepti

Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome

✍ Geoffrey Thiele; Molly Bicak; Helen Grierson; Patrick Lai; Purtilo David 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 817 KB

Correlation between the presence of anti

Correlation between the presence of antibodies to the Epstein-barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis

✍ Thomas B. Sculley; John H. Pope; Ron A. Hazelton 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a

Synthetic peptides deduced from the amin

Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): Antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man

✍ Kerstin Falk; Annika Linde; Donald Johnson; Evelyne Lennette; Ingemar Ernberg; Å 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 890 KB

## Abstract Studies on the antibody responses to various Epstein‐Barr virus (EBV) antigens have been instrumental in the understanding of the seroepidemiology and diagnosis of this viral infection and the subsequent carrier state. While antibodies to the viral capsid antigen (VCA), early antigen (E

Altered immune response to glycine-rich

Altered immune response to glycine-rich sequences of epstein-barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus

✍ Jorgen Petersen; Gary Rhodes; Jean Roudier; John H. Vaughan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Prior studies have shown that patients with rheumatoid arthritis (RA) have an increased number of circulating Epstein-Barr virus-infected B lymphocytes and elevated titers of antibody to Epstein-Barr nuclear antigen4 (EBNA-I), the major nuclear antigen ex- pressed in latently infected B cells. Howev

Cellular and humoral immune responses to

Cellular and humoral immune responses to synthetic peptides deduced from the amino-acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cells

✍ Joakim Dillner; Robert Szigeti; Werner Henle; Gertrude Henle; Richard A. Lerner; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 576 KB

Ten synthetic peptides containing 18-22 residues deduced from the amino-acid sequences of the EBV-encoded latentinfection-associated membrane protein (LMP) and the 2 principal nuclear antigens, EBNA-I and EBNA-2, were tested for their ability to induce lymphokine release from sensitized Tcells of EB